✨
AI Summary
- Dame Emma Walmsley confirms GSK will invest four times more in the US than the UK, citing America's scale, commercial opportunities, and favourable business environment
- The US accounts for over half of GSK's sales compared to just 2% in the UK, driving the company's investment prioritization strategy
- Walmsley warns that the UK must remain competitive to attract foreign investment in the life sciences sector